Rationale: To address the lung donor shortage, we obtained institutional review board and U.S. Food and Drug Administration approval to transplant lungs recovered from uncontrolled donation after circulatory determination of death donors (uDCDDs).
Chronic lung allograft dysfunction (CLAD) is the main limitation to long-term survival after lung transplantation. Although CLAD is usually not responsive to treatment, earlier identification may improve treatment prospects. In a nested case-control study, 1-year posttransplantation surveillance bronchoalveolar lavage (BAL) fluid samples were obtained from incipient CLAD (n = 9) and CLAD-free (n = 8) lung transplant recipients. Incipient CLAD cases were diagnosed with CLAD within 2 years, whereas control subjects were free from CLAD for at least 4 years after bronchoscopy. Transcription profiles in the BAL cell pellets were assayed with the HG-U133 Plus 2.0 microarray (Affymetrix, Santa Clara, CA). Differential gene expression analysis, based on an absolute fold change (incipient CLAD vs. no CLAD) greater than 2.0 and an unadjusted P value not exceeding 0.05, generated a candidate list containing 55 differentially expressed probe sets (51 up-regulated, 4 down-regulated). The cell pellets in incipient CLAD cases were skewed toward both innate and adaptive immune responses, suggesting that dysregulated immunity may precede a clinical diagnosis of CLAD. Both hierarchical clustering and a supervised machine learning tool were able to correctly categorize most samples into incipient CLAD and CLAD-free categories. A larger prospective investigation of a BAL cell pellet transcriptome as a biomarker for CLAD risk stratification is warranted. Lung wound-healing responses such as the epithelial-tomesenchymal transition (EMT) can be reparative or pathologic processes. During lung transplantation, wound healing must occur, yet unchecked responses can result in negative outcomes including bronchiolitis obliterans. A class of specialized proresolving lipid mediators (SPMs) derived from omega-3 fatty acids has been found to contribute to the regulation of wound healing, including both positive and negative actions on EMT-related pathways.
